## Abstract ## Background Bisphosphonates are known to be associated with osteonecrosis of the jaw. We assess factors underlying the success of surgical treatment in patients with bisphosphonateβrelated osteonecrosis of the jaw (BRONJ). ## Methods Fiftyβeight patients were investigated 6 months
β¦ LIBER β¦
Surgical treatment of bisphosphonate related osteonecrosis of the jaws
- Book ID
- 119336026
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 164 KB
- Volume
- 114
- Category
- Article
- ISSN
- 2212-4403
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Factors influencing surgical treatment o
β
Arno Wutzl; Sebastian Pohl; Irene Sulzbacher; Rudolf Seemann; GΓΌnter Lauer; Rolf
π
Article
π
2011
π
John Wiley and Sons
π
English
β 480 KB
π 2 views
Radical surgical treatment of bisphospho
β
I Hewson; D Syme; F Bruscino-Raiola
π
Article
π
2012
π
Australian Dental Association
π
English
β 554 KB
The outcomes of conservative and surgica
β
Z. Jabbour; M. El-Hakim; P. Mesbah-Ardakani; J.E. Henderson; R. Albuquerque Juni
π
Article
π
2012
π
Elsevier Science
π
English
β 297 KB
Use of buccal fat pad in the surgical tr
π
Article
π
2012
π
Elsevier
π
English
β 164 KB
Treatment results of bisphosphonate-rela
β
Arno Wutzl; Edwin Biedermann; Felix Wanschitz; Rudolf Seemann; Clemens Klug; Arn
π
Article
π
2008
π
John Wiley and Sons
π
English
β 238 KB
π 2 views
## Abstract ## Background. Osteonecrosis of the jaws occurs after the administration of bisphosphonates. An unequivocal treatment strategy is yet to be devised. We assess the treatment of patients with bisphosphonateβrelated osteonecrosis of the jaws (BRONJ). ## Methods. The investigators studie
Treatment protocols of bisphosphonate-re
β
Athanassios Kyrgidis; Georgios Koloutsos; Konstantinos Vahtsevanos
π
Article
π
2009
π
John Wiley and Sons
π
English
β 48 KB
π 2 views
We read with great interest the article by Wutzl et al, 1 reporting a well-designed prospective study for the treatment of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in a cohort of multiple myeloma, breast cancer, and other diseases in patients. The authors duly report patients' under